FGFR1 and obesity due to melanocortin 4 receptor deficiency: In this manuscript, we used growth in ultra-low attachment conditions to develop a novel phenotypic transformation HTS assay using FGF2/FGFR1 signaling as the target-based mechanism to identify chemopreventive agents for obesity-associated epithelial cancers.